| Literature DB >> 35911158 |
Xiaoxue Wang1, Ping Wang2,3, Haitao Du1, Na Li1, Tianyuan Jing1, Ru Zhang1, Wanying Qi1, Yanan Hu1, Tianyu Liu4, Lanxin Zhang5, Nan Xu2, Yi Wang2, Huimin Zhang2, Xiaoyan Ding2.
Abstract
Objective: Forsythia suspensa leaf (FSL) has been used as a health tea in China for centuries. Previous experiments have proved that FSL extract has a good effect on the antirespiratory syncytial virus (RSV) in vitro, but its exact mechanism is not clear. Therefore, this study aims to determine the active components and targets of FSL and further explore its anti-RSV mechanism.Entities:
Year: 2022 PMID: 35911158 PMCID: PMC9328944 DOI: 10.1155/2022/5643345
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.650
Main hemical composition of FSL.
| NO. | Compound | Molecular formula | Ion mode | Mzmed | RT/min | Peak area |
|---|---|---|---|---|---|---|
| 1 | (+)-Pinoresinol | C20H22O6 | [M-H]− | 357.13 | 6.56 | 791229617.70 |
| 2 | (+)-Pinoresinol-4-O-beta-D-glucopyraside | C26H32O111 | [M-H]− | 519.19 | 6.56 | 4166509751.00 |
| 3 | Salidroside | C14H20O7 | [M-H]− | 299.11 | 2.98 | 416030123.60 |
| 4 | Quercetin | C15H10O7 | [M + H]+ | 303.05 | 6.60 | 883627.57 |
| 5 | Hyperoside | C21H20O122 | [M-H]− | 463.08 | 6.08 | 7594792.25 |
| 6 | Caffeic acid | C9H8O4 | [M-H]− | 179.03 | 4.01 | 10694238742.00 |
| 7 | Phillyrin | C27H34O111 | [M-H]− | 579.20 | 7.73 | 7458440880.00 |
| 8 | Chlorogenic acid | C16H18O9 | [M-H]− | 353.08 | 3.57 | 110358675.20 |
| 9 | Kaempferol | C15H10O6 | [M-H]− | 285.03 | 8.89 | 355385.01 |
| 10 | 3-Hydroxybenzaldehyde | C7H6O2 | [M-H]− | 121.02 | 4.21 | 188945020.50 |
| 11 | Ferulic acid | C10H10O4 | [M-H]− | 193.04 | 4.49 | 4914965.43 |
| 12 | P-Hydroxyphenyl acrylic acid | C9H8O3 | [M-H]− | 163.03 | 4.65 | 10697330.91 |
| 13 | Secoisolariciresinol | C20H26O6 | [M-H]− | 361.16 | 7.09 | 9828539.83 |
| 14 | Calceolarioside B | C23H26O111 | [M + H]+ | 479.16 | 5.89 | 675251118.64 |
| 15 | Vanillic acid | C8H8O4 | [M-H]− | 167.03 | 3.94 | 48787513.71 |
| 16 | 4-Dicaffeoylquinic acid | C16H18O9 | [M-H]− | 353.08 | 3.88 | 80843996.30 |
| 17 | Quinic acid | C7H12O6 | [M-H]− | 191.05 | 4.57 | 57466022.97 |
| 18 | 3,4-Dihydroxybenzaldehyde | C7H6O3 | [M-H]− | 137.02 | 4.00 | 60332307.59 |
| 19 | Phillyrin B | C34H44O199 | [M-H]− | 755.23 | 6.00 | 820467980.90 |
| 20 | 4-Hydroxycinnamic acid | C9H8O3 | [M-H]− | 163.03 | 5.27 | 250776002.80 |
| 21 | Rhamnocitrin | C20H22O6 | [M-H]− | 357.13 | 27.22 | 22984449.73 |
| 22 | P-hydroxybenzoxal | C7H6O2 | [M-H]+ | 123.04 | 0.87 | 24287717.24 |
| 23 | Benzoic acid | C7H6O2 | [M + H]+ | 123.04 | 3.64 | 40801996.94 |
| 24 | Isophorone | C9H14O | [M-H]+ | 139.11 | 2.79 | 116897843.36 |
| 25 | Nivolumab | C8H8O3 | [M + H]+ | 153.06 | 5.21 | 62982567.92 |
| 26 | Camphor | C10H16O | [M + H]+ | 153.13 | 5.84 | 106102205.21 |
| 27 | Tryptamine | C10H12N2 | [M + H]+ | 161.11 | 26.80 | 7964958.56 |
| 28 | 2-Coumarin | C9H8O3 | [M + H]+ | 165.06 | 3.83 | 43963794.17 |
| 29 | P-Hydroxycinnamic acid | C9H8O3 | [M + H]+ | 165.06 | 4.58 | 9310132.79 |
| 30 | Paeonol | C9H10O3 | [M + H]+ | 167.07 | 3.22 | 30106741.86 |
| 31 | Homogentisic acid | C8H8O4 | [M + H]+ | 169.05 | 1.24 | 89280908.15 |
| 32 | Geranic acid | C10H16O2 | [M + H]+ | 169.12 | 1.02 | 56272751.98 |
| 33 | 6,7-Dihydroxy-4-methylcoumarin | C10H8O4 | [M + H]+ | 193.05 | 7.40 | 11318256.46 |
| 34 | Scopolactone | C10H8O4 | [M + H]+ | 193.05 | 0.45 | 6146412.70 |
| 35 | Yokogawa ligustilide A | C12H16O2 | [M + H]+ | 193.12 | 8.71 | 9992106.14 |
| 36 | Dihydrokaempferol (colombian aglycone) | C14H14O4 | [M + H]+ | 285.05 | 1.74 | 1054100.46 |
| 37 | Propethrin | C19H26O3 | [M + H]+ | 303.20 | 7.44 | 37631362.46 |
| 38 | Sanguinarine | C15H10O7 | [M + H]+ | 303.05 | 8.10 | 44076.10 |
| 39 | Boswellic acid | C20H30O2 | [M + H]+ | 303.23 | 12.14 | 3471892.58 |
| 40 | (-)-Epigallocatechin | C15H14O7 | [M + H]+ | 307.08 | 6.12 | 282532593.99 |
| 41 | Gallocatechins | C15H14O7 | [M + H]+ | 307.08 | 4.69 | 7539336.66 |
| 42 | Caffeinol | C20H28O3 | [M + H]+ | 317.21 | 10.82 | 33616062.68 |
| 43 | Isorhamnetin | C16H12O7 | [M + H]+ | 317.07 | 6.46 | 1930112.37 |
| 44 | Ginkgoneolic acid | C20H32O3 | [M + H]+ | 321.24 | 11.45 | 8274443.51 |
| 45 | Isoform aconitin | C20H27NO3 | [M + H]+ | 330.21 | 6.89 | 17743758.07 |
| 46 | Columbin | C20H22O6 | [M + H]+ | 359.15 | 6.13 | 15304281.36 |
| 47 | Genistein B | C19H18O7 | [M + H]+ | 359.11 | 1.14 | 98701853.52 |
| 48 | Rosmarinic acid | C18H16O8 | [M + H]+ | 361.09 | 4.57 | 400615.12 |
| 49 | Curcumin | C21H20O6 | [M + H]+ | 369.13 | 9.96 | 5345129.23 |
| 50 | Aucubin | C15H22O9 | [M + H]+ | 369.12 | 2.21 | 3112265.84 |
| 51 | Forsytheins | C21H24O6 | [M + H]+ | 373.17 | 7.78 | 81425864.68 |
| 52 | Paraphyllin | C22H33NO4 | [M + H]+ | 376.25 | 4.94 | 21317926.78 |
| 53 | Loganic acid | C16H24O100 | [M + H]+ | 377.15 | 4.69 | 61961252.11 |
| 54 | Eleutheroside | C16H22O9 | [M + H]+ | 381.12 | 2.97 | 39828726.65 |
| 55 | Pseudolaric acid C | C21H26O7 | [M + H]+ | 391.18 | 8.97 | 33835218.13 |
| 56 | Afzelin | C21H20O100 | [M + H]+ | 433.11 | 6.37 | 1241906.35 |
| 57 | Astragalin | C21H20O111 | [M + H]+ | 449.11 | 6.19 | 5731468.55 |
| 58 | Isosakuranin | C22H24O100 | [M + H]+ | 449.15 | 3.63 | 58302445.74 |
| 59 | Asperuloside acid | C18H24O122 | [M + H]+ | 455.12 | 4.25 | 1549292.02 |
| 60 | Berberine | C26H30O7 | [M + H]+ | 455.20 | 7.44 | 653736.80 |
| 61 | Forsythoside E | C20H30O122 | [M + H]+ | 463.18 | 3.20 | 119659925.90 |
| 62 | Methylnissolin-3-O-glucoside | C23H26O100 | [M + H]+ | 463.16 | 6.75 | 6053442.72 |
| 63 | Isoquercitrin | C21H20O122 | [M + H]+ | 465.10 | 6.10 | 35289037.57 |
| 64 | Daphylloside | C19H26O122 | [M + H]+ | 469.13 | 5.22 | 125152971.49 |
| 65 | Calceolarioside A | C23H26O111 | [M + H]+ | 501.14 | 3.20 | 29042008.47 |
| 66 | Rutin | C27H30O166 | [M + H]+ | 611.16 | 5.92 | 799317923.21 |
| 67 | Isorhamnetin-3-o-neohesperidin | C28H32O166 | [M + H]+ | 625.18 | 6.45 | 3038686.75 |
Figure 1Active ingredient of FSL-RSV pneumonia target network.
Figure 2(a) PPI network of FSL anti-RSV; (b) GO enrichment analysis of anti-RSV target biological processes of FSL; (c) bubble diagram of KEGG enrichment pathway, the main target of FSL.
FSL compounds-potential target proteins docking score.
| Target | Compound | Docking Score |
|---|---|---|
| TP53 (PDB ID : 1YC5) | Cryptochlorogenic acid | −8.146 |
| Phenyl sthanol glucoside B | −7.619 | |
| Rosmarinic acid | −7.617 | |
| Phenethyl acetate | −7.608 | |
| Aucubin | −7.533 | |
|
| ||
| STAT3 (PDB ID : 6NJS) | Phillyrin | −5.269 |
| P-Hydroxyphenyl acrylic | −4.966 | |
| 4-Hydroxycinnamic acid | −4.966 | |
| Paeonol | −4.966 | |
| Vanillic acid | −4.907 | |
|
| ||
| MAPK1(PDB ID : 2Y9Q) | Phillygenin | −8.627 |
| Phenethyl acetate | −8.602 | |
| Cryptochlorogenic acid | −8.362 | |
| Quercetin | −8.353 | |
| Loganine acid | −8.206 | |
|
| ||
| AKT1(PDB ID: 1UNQ) | Rutin | −6.057 |
| Vanillic acid | −5.956 | |
| Dextroquinic acid | −5.854 | |
| Dihydrobehenyl alcohol | −5.756 | |
| Methyl paraben | −5.611 | |
|
| ||
|
|
| −7.383 |
| Phillyrin | −7.129 | |
| Cryptochlorogenic acid | −6.783 | |
| Phenethyl acetate | −6.758 | |
| Salidroside | −6.744 | |
Figure 3Molecular docking of active components of FSL with core targets. The yellow dotted line represents H-bond, and the green dotted line represents Pi-cation.
TC0 on HEp-2 cells in each administration group (n = 6).
| Name | TC0( |
|---|---|
| Cryptochlorogenic acid | 125 |
| Phillygenin | 250 |
| Phillyrin | 1000 |
| Rosmarinic acid | 250 |
| Rutin | 500 |
| Ribavirin | 250 |
TC0, maximal atoxic concentration.
Figure 4The effect of the active ingredients of FSL on the survival rate of RSV-infected HEp-2 cells(‾x ± s, n = 6) (a). Normal group; (b) model group; (c) 125 μg/mL cryptochlorogenic acid; (d) 62.5 μg/mL phillyringenin; (e) 1000 μg/mL phillyrin; (f) 125 μg/mL rosmarinic acid; (g) 62.5 μg/mL rutin; (h) 2500 μg/mL water extract of FSL; (I) 250 μg/mL ribavirin; compared with normal groupP < 0.05; compared with model group #P < 0.05.
Figure 5Effects of rosmarinic acid and phillyrin on PI3K/AKT signaling pathway-related proteins ( ‾x ± s, n = 3).
Figure 6Model for prolonged cell survival after RSV infection.